Australia markets closed

Arcadia Biosciences Inc (17D.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
2.8800-0.0400 (-1.37%)
At close: 08:04AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-7,020
-13,981
-15,376
-14,660
-4,655
-
Depreciation & amortisation
267
287
479
1,045
662
-
Deferred income taxes
-
-
-
0
-107
0
Stock-based compensation
643
717
1,106
1,541
2,042
-
Change in working capital
-3,227
-2,744
1,050
-2,920
-11,463
-
Accounts receivable
-
184
592
-40
-1,119
-
Inventory
-2,079
-2,419
1,118
-2,383
-9,751
-
Accounts payable
-1,051
-522
-757
-372
-580
-
Other working capital
-15,056
-15,299
-14,049
-26,875
-32,553
-
Other non-cash items
6,006
6,439
196
492
-4,180
-
Net cash provided by operating activities
-15,038
-15,294
-13,977
-25,868
-30,218
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-5
-72
-1,007
-2,335
-
Acquisitions, net
-
-
0
-4,250
-500
0
Purchases of investments
-
-7,525
0
0
-1,292
-
Sales/maturities of investments
-
2,502
0
21,846
18,250
-
Net cash used for investing activities
-4,655
-4,344
1,417
16,608
17,284
-
Cash flows from financing activities
Debt repayment
-
-
0
-2,146
-34
-8
Common stock issued
0
5,997
5,000
25,147
8,000
-
Other financing activities
-
-497
-488
-1,162
63
-
Net cash used provided by (used for) financing activities
12
5,512
4,519
21,900
20,560
-
Net change in cash
-19,681
-14,126
-8,041
12,642
7,626
-
Cash at beginning of period
22,998
20,644
28,685
16,043
8,417
-
Cash at end of period
3,317
6,518
20,644
28,685
16,043
-
Free cash flow
Operating cash flow
-15,038
-15,294
-13,977
-25,868
-30,218
-
Capital expenditure
-
-5
-72
-1,007
-2,335
-
Free cash flow
-15,056
-15,299
-14,049
-26,875
-32,553
-